Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
Acer Therapeutics Inc. (ACER)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Jun-05-23 | Mar-31-23 | Mar-05-23 | Dec-31-22 | Dec-05-22 | Sep-30-22 | Jun-30-22 |
| | 10-Q | 8-K | 10-Q | 8-K | 10-K | 8-K | 10-Q | 10-Q |
| Revenues | 100.0% | | 100.0% | | | | 100.0% | 100.0% |
| Cost of goods sold | 200.0% | | 199.0% | | | | 181.0% | 179.6% |
| Gross profit | -100.0% | | -99.0% | | | | 100.0% | 100.0% |
| Selling, general and administrative | 606.5% | | 552.5% | | | | | 5759.8% |
| Research and development | | | | | | | 744.9% | |
| General and administrative | | | | | | | 1253.8% | |
| Depreciation | | | | | | | -1.0% | |
| EBIT | -1264.9% | | -1374.2% | | | | -710.0% | -336.0% |
| Pre-tax income | -928.6% | | -1260.6% | | | | -491.4% | -293.4% |
| Income taxes | 0.0% | | 0.0% | | | | 0.0% | 0.0% |
| Net income | -928.6% | | -1260.6% | | | | -491.4% | -293.4% |
|